Recent developments in healthcare range from pharmaceutical waste reduction and new drug approvals to advancements in obesity research and pediatric diagnostics.
Key Points
Pharmacists in England are urging increased medication reviews to address the annual 480 million pound waste of NHS medicines, which is estimated to be equivalent to filling 75 swimming pools.
Researchers have found that a bitter hop extract may assist adults with obesity in losing nearly 5 kg of fat over 24 weeks while successfully preserving muscle mass.
The U.S. FDA has scheduled an advisory committee meeting for September to review Grail's Galleri test, a multi-cancer early detection screening tool.
A study indicates that obesity and advanced age increase the likelihood of severe asparaginase-associated toxicities during induction therapy for young patients with acute lymphoblastic leukemia.
New research suggests that using BMI or waist circumference is as accurate as more complex criteria proposed by The Lancet Commission for diagnosing obesity.
The MHRA has approved remibrutinib, an oral BTK inhibitor, providing a new treatment alternative for adults suffering from chronic spontaneous urticaria.
A study in Germany reveals that medical diagnosis codes significantly underrepresent instances of physical child abuse compared to actual hospital documentation.
Physicians are increasingly leveraging platforms like YouTube as a tool to expand patient education beyond the traditional clinical setting and to explore new income streams.